Company profile
ABL Bio Inc.
A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.
- Industry
- Biotechnology Research
- Employees
- 65
- Headquarters
- Seongnam-si, Gyeonggi-do
- Founded
- 2016
- LinkedIn followers
- 3,284
- Office locations
- 1
ABL Bio Inc. company summary
ABL Bio Inc. is a company in the Biotechnology Research industry, headquartered in Seongnam-si, Gyeonggi-do, founded in 2016. On LinkedIn the company has around 65 employees and 3,284 followers. Its listed specialties include Biotechnology, Bispecific Antibody, BBB Penetration, Immuno-Oncology, ADC.
What technology does ABL Bio Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ABL Bio Inc.
ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives. With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers. In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration. We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com
Specialties
Where is ABL Bio Inc. located?
ABL Bio Inc. lists 1 location.
Compare companies similar to ABL Bio Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ABL Bio Inc. ablbio.com | Biotechnology Research | 65 | 2016 | Seongnam-si, Gyeonggi-do |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ABL Bio Inc.
What does ABL Bio Inc. do?
ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives. With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers. In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration. We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com
How many employees does ABL Bio Inc. have?
ABL Bio Inc. has around 65 employees on LinkedIn.
Where is ABL Bio Inc. headquartered?
ABL Bio Inc. is headquartered in Seongnam-si, Gyeonggi-do.
When was ABL Bio Inc. founded?
ABL Bio Inc. was founded in 2016.
Build a lead list from companies like ABL Bio Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.